Balance Sheet
Cash Flow Statement
Capital ExpendituresCash from Financing ActivitiesCash from Investing ActivitiesCash from OperationsChange in Account PayablesChange in Accured ExpensesChange in Acquisitions & DivestmentsChange in CashChange in ReceivablesDepreciation & Amortization (CF)Free Cash FlowGains from Investment SecuritiesGains from Sales and DivestituresNet Cash FlowNet IncomeNon-cash ItemsOther Working Capital ChangesShare-based CompensationShares Issued
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Assembly Biosciences (ASMB) Non-cash Items (2018 - 2025)

Assembly Biosciences has reported Non-cash Items over the past 8 years, most recently at $714173.0 for Q4 2025.

  • Quarterly results put Non-cash Items at $714173.0 for Q4 2025, down 48.36% from a year ago — trailing twelve months through Dec 2025 was $714173.0 (down 48.36% YoY), and the annual figure for FY2025 was $714173.0, down 48.36%.
  • Non-cash Items for Q4 2025 was $714173.0 at Assembly Biosciences, down from $1.4 million in the prior quarter.
  • Over the last five years, Non-cash Items for ASMB hit a ceiling of $4.3 million in Q1 2021 and a floor of $1000.0 in Q3 2022.
  • Median Non-cash Items over the past 5 years was $343000.0 (2021), compared with a mean of $787891.1.
  • Biggest five-year swings in Non-cash Items: crashed 99.86% in 2022 and later soared 138200.0% in 2024.
  • Assembly Biosciences' Non-cash Items stood at $53000.0 in 2021, then tumbled by 98.11% to $1000.0 in 2022, then changed by 0.0% to $1000.0 in 2023, then soared by 138200.0% to $1.4 million in 2024, then plummeted by 48.36% to $714173.0 in 2025.
  • The last three reported values for Non-cash Items were $714173.0 (Q4 2025), $1.4 million (Q4 2024), and $1000.0 (Q4 2023) per Business Quant data.